Skip to content

The mechanism of regulating neutrophil extracellular traps in the treatment of diabetic foot ulcers using filiform fire needle wound pricking

The mechanism of regulating neutrophil extracellular traps in the treatment of diabetic foot ulcers using filiform fire needle wound pricking

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000055
Enrollment
Unknown
Registered
2025-01-10
Start date
2024-11-30
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic foot ulcers

Interventions

Control group:Wound dressing with iodine tincture
Experimental group:Filiform fire needle wound pricking

Sponsors

Dongfang Hospital Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Meets the diagnostic criteria for diabetic foot; (2) Aged = 18 years and = 80 years; (3) Wound area between 1-25 cm² after debridement; (4) WIfI wound grade 1-2 ischemia grade 0-2 and foot infection grade 1-2; (5) Only one ulcerative lesion present on the limb to be studied; (6) Able to understand the study and cooperate in completing it; (7) Voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Coagulation disorders or fragile tissue after debridement that is prone to bleeding and difficult to stop; (2) Undergoing vascular bypass interventional treatment or amputation (toe) surgery during the study intervention period; (3) Unable to tolerate acupuncture treatment; (4) Comorbidities including severe cardiovascular cerebrovascular respiratory liver or kidney diseases presence of malignancies severe infections or other conditions that may affect the study.

Design outcomes

Primary

MeasureTime frame
Wound healing rate;curative effect evaluation criteria;

Secondary

MeasureTime frame
Wound symptom score;Wound healing status;Serum NETs and inflammatory markers;VAS pain score;

Countries

China

Contacts

Public ContactCao Jianchun

Dongfang Hospital Beijing University of Chinese Medicine

caojianchun01@163.com13521039608

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026